Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Guallar, Eliseo ^a,b,c,d   Banegas, José R ^e,f   Blasco Colmenares, Elena ^a   Jiménez, F Javier ^g   Dallongeville, Jean ^h   Halcox, Julian P ⁱ   Borghi, Claudio ^j   Massá González, Elvira L ^g   Tafalla, Mánica ^g   Perk, Joep ^k   De Backer, Guy ^l   Steg, Philippe G ^m   Rodríguez Artalejo, Fernando ^e,f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g ASTRAZENECA   (United Kingdom)

^h INSTITUT PASTEUR DE LILLE   (France)

ⁱ CARDIFF UNIVERSITY   (United Kingdom)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k LINNAEUS UNIVERSITY   (Sweden)

^l GHENT UNIVERSITY   (Belgium)

^m INSERM   (France)

more..

Author keywords

cardiovascular disease; control; mortality; risk factors; SCORE

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EUROPE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; OUTPATIENT DEPARTMENT; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING;

AGED; AMBULATORY CARE FACILITIES; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EUROPE; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING;

EID: 80052860267     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-704     Document Type: Article

References (31)

1. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, et al. Eur J Cardiovasc Prev Rehabil 2007 14 Suppl 2 1 113 18091132
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection E, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA 2001 285 19 2486 2497 10.1001/jama.285.19.2486 11368702
3. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Reiner Z, Keil U, Eur J Cardiovasc Prev Rehabil 2010 17 5 530 540 10.1097/HJR. 0b013e3283383f30 20577089
4. Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, et al. Circulation 2010 121 7 948 954 20177011
5. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, et al. Eur Heart J 2003 24 11 987 1003 10.1016/S0195-668X(03)00114-3 12788299 (Pubitemid 36712275)
6. Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA). Rodriguez-Artalejo F, Guallar E, Borghi C, Dallongeville J, De Backer G, Halcox JP, Hernandez-Vecino R, Jimenez FJ, Masso-Gonzalez EL, Perk J, et al. BMC Public Health 2010 10 382 10.1186/1471-2458-10-382 20591142
7. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2010 33 Suppl 1 62 69 20042775
8. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, et al. Lancet 2010 375 9733 2215 2222 10.1016/S0140-6736(10)60484-9 20609967
9. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH, Ann Intern Med 2004 141 6 421 431 15381515
10. Major lipids, apolipoproteins, and risk of vascular disease. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, et al. JAMA 2009 302 18 1993 2000 19903920
11. Estimates of global mortality attributable to smoking in 2000. Ezzati M, Lopez AD, Lancet 2003 362 9387 847 852 10.1016/S0140-6736(03)14338-3 13678970 (Pubitemid 37130092)
12. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, et al. JAMA 2003 289 18 2363 2369 10.1001/jama.289.18.2363 12746359 (Pubitemid 37430168)
13. The global burden of diabetes and its complications: an emerging pandemic. van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B, Eur J Cardiovasc Prev Rehabil 2010 17 Suppl 1 3 8 20489418
14. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U, Lancet 2009 373 9667 929 940 10.1016/S0140-6736(09)60330-5 19286092
15. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Rother J, et al. JAMA 2006 295 2 180 189 10.1001/jama.295.2.180 16403930 (Pubitemid 43076437)
16. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Steinberg BA, Bhatt DL, Mehta S, Poole-Wilson PA, O'Hagan P, Montalescot G, Ballantyne CM, Cannon CP, Am Heart J 2008 156 4 719 727 10.1016/j.ahj.2008.05.020 18926153
17. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Wang YR, Alexander GC, Stafford RS, Arch Intern Med 2007 167 2 141 147 10.1001/archinte.167.2.141 17242314 (Pubitemid 46151611)
18. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Waters DD, Brotons C, Chiang CW, Ferrieres J, Foody J, Jukema JW, Santos RD, Verdejo J, Messig M, McPherson R, et al. Circulation 2009 120 1 28 34 10.1161/CIRCULATIONAHA.108.838466 19546386
19. Global burden of hypertension: analysis of worldwide data. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J, Lancet 2005 365 9455 217 223 15652604 (Pubitemid 40138015)
20. Global burden of blood-pressure-related disease, 2001. Lawes CM, Vander Hoorn S, Rodgers A, Lancet 2008 371 9623 1513 1518 10.1016/S0140-6736(08)60655-8 18456100 (Pubitemid 351626187)
21. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. Hypertension 2003 42 6 1206 1252 10.1161/01.HYP.0000107251.49515. c2 14656957 (Pubitemid 37553153)
22. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, et al. Lancet 2005 366 9493 1267 1278 16214597
23. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Law MR, Wald NJ, Thompson SG, BMJ 1994 308 6925 367 372 8043072 (Pubitemid 24078498)
24. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M, Nicotine Tob Res 2009 11 1 12 24 10.1093/ntr/ntn010 19246437
25. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R, Lancet 2007 370 9604 2044 2053 10.1016/S0140-6736(07)61698-5 18063027 (Pubitemid 50007973)
26. IPCRG Consensus statement: tackling the smoking epidemic-practical guidance for primary care. van Schayck OC, Pinnock H, Ostrem A, Litt J, Tomlins R, Williams S, Buffels J, Giannopoulos D, Henrichsen S, Kaper J, et al. Prim Care Respir J 2008 17 3 185 193 10.3132/pcrj.2008.00060 18769845
27. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, et al. Circulation 2009 119 2 351 357 10.1161/CIRCULATIONAHA.108.191305 19095622
28. Evolution of all-causes and cardiovascular mortality in the age-group 75-84 years in Europe during the period 1970-1996; a comparison with worldwide changes. Kesteloot H, Sans S, Kromhout D, Eur Heart J 2002 23 5 384 398 10.1053/euhj.2001.2839 11846496 (Pubitemid 35204199)
29. The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway. Lindman AS, Veierod MB, Pedersen JI, Tverdal A, Njolstad I, Selmer R, Eur J Cardiovasc Prev Rehabil 2007 14 4 501 507 10.1097/HJR.0b013e328011490a 17667638 (Pubitemid 47229729)
30. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Kesteloot H, Sans S, Kromhout D, Eur Heart J 2006 27 1 107 113 16204263 (Pubitemid 41785939)
31. High cardiovascular mortality in Russia cannot be explained by the classical risk factors. The Arkhangelsk Study 2000. Averina M, Nilssen O, Brenn T, Brox J, Kalinin AG, Arkhipovsky VL, Eur J Epidemiol 2003 18 9 871 878 10.1023/A:1025626202235 14561046 (Pubitemid 37169023)